Vaxil Bio Stock Shares Owned By Insiders

VXL Stock  CAD 0.01  0.01  33.33%   
Vaxil Bio fundamentals help investors to digest information that contributes to Vaxil Bio's financial success or failures. It also enables traders to predict the movement of Vaxil Stock. The fundamental analysis module provides a way to measure Vaxil Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxil Bio stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vaxil Bio Company Shares Owned By Insiders Analysis

Vaxil Bio's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current Vaxil Bio Shares Owned By Insiders

    
  8.16 %  
Most of Vaxil Bio's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxil Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Vaxil Shares Owned By Insiders Driver Correlations

Understanding the fundamental principles of building solid financial models for Vaxil Bio is extremely important. It helps to project a fair market value of Vaxil Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Vaxil Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vaxil Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vaxil Bio's interrelated accounts and indicators.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 8.16% of Vaxil Bio are shares owned by insiders. This is 46.25% lower than that of the Biotechnology sector and 42.45% lower than that of the Health Care industry. The shares owned by insiders for all Canada stocks is 19.13% higher than that of the company.

Vaxil Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxil Bio's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vaxil Bio could also be used in its relative valuation, which is a method of valuing Vaxil Bio by comparing valuation metrics of similar companies.
Vaxil Bio is currently under evaluation in shares owned by insiders category among related companies.

Vaxil Bio Current Valuation Drivers

We derive many important indicators used in calculating different scores of Vaxil Bio from analyzing Vaxil Bio's financial statements. These drivers represent accounts that assess Vaxil Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaxil Bio's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap3.1M30.5M10.2M2.7M3.4K3.3K
Enterprise Value3.0M29.0M8.0M1.2M2.5K2.4K

Vaxil Fundamentals

About Vaxil Bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vaxil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxil Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxil Bio's short interest history, or implied volatility extrapolated from Vaxil Bio options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxil Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Vaxil Stock analysis

When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Please note, there is a significant difference between Vaxil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.